| Line item | 2025-12-31 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – | – |
| SG&A | $425.58K | $426.97K | $1.60M | $1.16M | $818.86K | $616.97K | $629.97K |
| Operating Income | – | – | – | – | – | – | – |
| Interest Expense | $25.20K | $24.93K | $99.00K | $101.27K | – | – | – |
| Tax Expense | – | – | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $227.31K | – | -$3.91M | – | -$32.58K | – | – |
| EPS (basic) | – | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – |